(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-03 View latest technical analysis
10 day averaged volume of Halozyme Therapeutics is 1343890
Date | Daily Closing Price | Open | High | Low | Volume |
03 Mon Mar 2025 | 57.96 | 59.14 | 59.90 | 57.66 | 1.053 times |
28 Fri Feb 2025 | 59.15 | 57.55 | 59.16 | 57.49 | 0.919 times |
27 Thu Feb 2025 | 57.70 | 57.99 | 58.97 | 57.65 | 0.655 times |
26 Wed Feb 2025 | 57.92 | 58.02 | 58.70 | 57.45 | 0.762 times |
25 Tue Feb 2025 | 57.99 | 58.60 | 58.98 | 57.50 | 0.892 times |
24 Mon Feb 2025 | 58.50 | 57.93 | 59.35 | 57.49 | 1.014 times |
21 Fri Feb 2025 | 57.75 | 58.00 | 58.74 | 57.32 | 0.967 times |
20 Thu Feb 2025 | 57.44 | 57.35 | 57.73 | 56.07 | 1.148 times |
19 Wed Feb 2025 | 57.77 | 58.98 | 60.67 | 56.77 | 1.664 times |
18 Tue Feb 2025 | 57.90 | 58.84 | 58.90 | 57.61 | 1.234 times |
My analysis of stock is bullish for shortterm, and stock might move up till 58.4 or till 59.1. Use a stoploss of 57.77 and if this stock hits its stoploss, then it can fall down till 57.14
Share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Target | 42.01 |
Downside Target | 46.39 |
Downside Target | 47.52 |
Downside Target | 49.79 |
Downside Target | 54.96 |
Downside Target | 56.07 |
Upside Target | 59.35 |
Upside Target | 59.40 |
Upside Target | 59.90 |
Upside Target | 60.67 |
Upside Target | 62.13 |
Intraday share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Intraday Target | 57.11 |
Downside Intraday Target | 56.27 |
Upside Intraday Target | 59.35 |
Upside Intraday Target | 60.75 |
Upside Intraday Target | 58.51 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
Date | Weekly Closing Price | Open | High | Low | Volume |
03 Mon Mar 2025 | 57.96 | 59.14 | 59.90 | 57.66 | 0.248 times |
28 Fri Feb 2025 | 59.15 | 57.93 | 59.35 | 57.45 | 0.846 times |
21 Fri Feb 2025 | 57.75 | 58.84 | 60.67 | 56.07 | 1.38 times |
14 Fri Feb 2025 | 58.29 | 57.10 | 59.40 | 56.51 | 0.973 times |
07 Fri Feb 2025 | 57.10 | 55.12 | 58.20 | 54.96 | 0.923 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
Date | Monthly Closing Price | Open | High | Low | Volume |
03 Mon Mar 2025 | 57.96 | 59.14 | 59.90 | 57.66 | 0.063 times |
28 Fri Feb 2025 | 59.15 | 55.12 | 60.67 | 54.96 | 0.706 times |
31 Fri Jan 2025 | 56.64 | 48.23 | 57.46 | 47.52 | 1.496 times |
31 Tue Dec 2024 | 47.81 | 48.20 | 49.79 | 46.39 | 0.444 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 57.99 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 57.99 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.